Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial

2023/12/04 by Philippe Généreux, Allan Schwartz, Brad Oldemeyer +8 · 7 citations
Medicine · #Cardiac Valve Diseases and Treatments #Cardiovascular Function and Risk Factors #Congenital Heart Disease Studies

paper · doi:10.1016/j.ahj.2023.11.019

Cited by

• Transcatheter Aortic Valve Implantation Current Indications and Future Directions. [europepmc]
• Transcatheter Aortic Valve Replacement: Latest Advances and Prospects. [europepmc]
• Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial. [europepmc]
• Patient risk evaluation for transcatheter aortic valve replacement (PRE-TAVR) - identification of real-time predictors of short- and long-term mortality. [europepmc]
• Global, regional, and national burdens of non-rheumatic calcific aortic valve disease in middle-aged and elderly populations from 1990 to 2021 and predictions up to 2050: trends, predictions, and health inequity. [europepmc]
• Nationwide trends and in-hospital outcomes of surgical versus transcatheter aortic valve replacement in Japan: a real-world analysis using administrative data. [europepmc]
• Management of coronary artery disease in patients referred for transcatheter aortic valve replacement. [europepmc]